Teva's CGRP Inhibitor Fails In Chronic Cluster Headaches, Continues In Episodic

 
• By Mandy Jackson

Unlike the migraine space, there is only one competitor for Teva's CGRP inhibitor in cluster headaches, but that opportunity narrowed with fremanezumab's failure in chronic cluster headaches, though a trial in episodic cluster headaches is ongoing.

Closed up finger on keyboard with word CLINICAL TRIALS

More from Neurological

More from Therapy Areas